KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Assets Average (2016 - 2026)

Bio-Rad Laboratories has reported Assets Average over the past 17 years, most recently at $10.2 billion for Q1 2026.

  • Quarterly Assets Average rose 110.57% to $10.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.2 billion through Mar 2026, up 110.57% year-over-year, with the annual reading at $10.0 billion for FY2025, 112.94% up from the prior year.
  • Assets Average was $10.2 billion for Q1 2026 at Bio-Rad Laboratories, roughly flat from $10.1 billion in the prior quarter.
  • Over five years, Assets Average peaked at $13.5 billion in Q2 2022 and troughed at $146.0 million in Q1 2024.
  • The 5-year median for Assets Average is $8.6 billion (2022), against an average of $8.4 billion.
  • Year-over-year, Assets Average plummeted 97.86% in 2024 and then skyrocketed 3212.4% in 2025.
  • A 5-year view of Assets Average shows it stood at $6.0 billion in 2022, then fell by 1.35% to $5.9 billion in 2023, then tumbled by 97.55% to $146.0 million in 2024, then surged by 6842.77% to $10.1 billion in 2025, then increased by 0.46% to $10.2 billion in 2026.
  • Per Business Quant, the three most recent readings for BIO's Assets Average are $10.2 billion (Q1 2026), $10.1 billion (Q4 2025), and $10.0 billion (Q3 2025).